Summary of evidence and Expert Committee recommendations
The Committee noted the advice from the WHO Secretariat that the WHO Guidelines for clinical
management of influenza are in the process of being updated, but the recommendations of
the guideline development group were not yet available. The Committee recommended that
no change be made to the current listing for oseltamivir on the Model Lists until the updated
guidelines and supporting evidence can be reviewed.